Sapphiros
Sapphiros is a healthcare investment platform that partners with and supports growth-stage diagnostic companies by providing capital, resources, and expertise. Their portfolio includes proprietary molecular detection technologies for rapid infectious disease testing, advanced printed electronics manufacturing, genetic and COVID-19 testing services, consumer-based diagnostic patches, and AI-driven computational biology solutions. The company aims to bridge the gap between present and future diagnostics, enabling near-patient and at-home testing with innovative technologies. Backed by global investment firm KKR, Sapphiros leverages a team of seasoned healthcare executives to drive transformative diagnostic innovations to market at scale.
Sapphiros
Sapphiros is a healthcare investment platform that partners with and supports growth-stage diagnostic companies by providing capital, resources, and expertise. Their portfolio includes proprietary molecular detection technologies for rapid infectious disease testing, advanced printed electronics manufacturing, genetic and COVID-19 testing services, consumer-based diagnostic patches, and AI-driven computational biology solutions. The company aims to bridge the gap between present and future diagnostics, enabling near-patient and at-home testing with innovative technologies. Backed by global investment firm KKR, Sapphiros leverages a team of seasoned healthcare executives to drive transformative diagnostic innovations to market at scale.